Elevated CSF dynorphin A [1-8] in Tourette's syndrome

Area of Science:

• Neuroscience
• Neurobiology
• Genetics

Background:

• Tourette's syndrome (TS) is a chronic neuropsychiatric disorder characterized by motor and phonic tics and behavioral issues like obsessive-compulsive disorder (OCD).
• Previous neuropathological studies suggested a role for dynorphin A in TS pathophysiology, noting decreased levels in specific brain regions.
• Endogenous opioids, including dynorphin, are concentrated in basal ganglia structures crucial for motor control and interact with dopaminergic systems.

Purpose of the Study:

• To investigate the role of dynorphin A in the pathobiology of Tourette's syndrome.
• To determine if dynorphin A concentrations in cerebrospinal fluid (CSF) correlate with TS symptom severity.

Main Methods:

• Collected CSF samples from 7 adult patients diagnosed with Tourette's syndrome.
• Measured concentrations of dynorphin A [1-8] in the CSF samples.
• Assessed the correlation between CSF dynorphin A levels and the severity of tics and obsessive-compulsive symptoms.

Main Results:

• Elevated concentrations of dynorphin A [1-8] were detected in the CSF of TS patients.
• Increased CSF dynorphin A levels were significantly associated with the severity of obsessive-compulsive symptoms.
• No significant association was found between CSF dynorphin A levels and tic severity.

Conclusions:

• Findings suggest that endogenous opioids, specifically dynorphin A, are implicated in the pathobiology of Tourette's syndrome and related disorders.
• The association with OCD symptoms suggests a potential role for dynorphin in the behavioral aspects of TS.
• While CSF studies have limitations, the results indicate a potential neurochemical marker for certain TS-related symptoms.